IGF1R and neuroblastoma: The remaining RAS/MAPK pathway-altered neuroblastoma lines, namely NB-Eb-C1, LAN-6, CHP-212, NBL-S, and SK-N-BE(2)-C, expressed IGF1R to a similar extent as the positive control cell line, MCF7.